Cardica, Inc. 

(Public, NASDAQ:CRDC)   Watch this stock   
Find more results for CRDC
Nov 11, 2009
CARDICA INC Shareholders Meeting
Oct 29, 2009
Q1 2010 CARDICA INC Earnings Conference Call - Webcast
Oct 29, 2009
Q1 2010 CARDICA INC Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2009
Net profit margin -173.55% -174.17%
Operating margin -176.22% -175.26%
EBITD margin - -165.97%
Return on average assets -111.76% -89.17%
Return on average equity -177.06% -124.32%
Employees 42 -

Address

900 Saginaw Drive
Redwood City, CA 94063
United States - Map
+1-650-3649975 (Phone)
+1-650-3643134 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com
Discussion Group - Google Finance

Cardica, Inc. discussed on blogs

Ranking 600+ Healthcare Stocks by Cash Flow per Share - NASD100 ... - Investor's Resources - NASD100.com - Daily Stock Rankings - 10 hours ago
Ranking Healthcare Stocks by Year-to-Date Performance - NASD100 ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 23, 2009

Description

Cardica, Inc. designs, manufactures and markets automated anastomotic systems used by cardiac surgeons to perform coronary bypass surgery. The Company’s business also includes the development of an endoscopic microcutter intended for use by general, thoracic, gynecologic, bariatric and urologic surgeons. It is also developing a patent foramen ovale (PFO) device in collaboration with Cook Incorporated (Cook). As of June 30, 2009, the Company sold its C-Port Distal Anastomosis Systems (C-Port systems) in the United States and Europe. C-Port systems include the C-Port xA system, the C-Port Flex A system and the C-Port X-CHANGE system. It also sells its PAS-Port Proximal Anastomosis System (PAS-Port system) in the United States and in Europe, and Japan through distributors. In addition to its commercialized cardiac surgery products, the Company has commenced development of the Cardica Microcutter, a multi-fire endolinear microcutter device based on its staple-on-a-strip technology.

Officers and directors

Kevin T. Larkin
Chairman of the Board
Age: 60
Bio & Compensation - Reuters
Bernard A. Hausen M.D., Ph.D.
President, Chief Executive Officer, Chief Medical Officer, Director
Age: 49
Bio & Compensation - Reuters
Robert Y. Newell
Chief Financial Officer, Vice President - Finance
Age: 61
Bio & Compensation - Reuters
Frederick M. Bauer
Vice President - Operations
Age: 55
Bio & Compensation - Reuters
Bryan D. Knodel Ph.D.
Vice President - Research & Development
Age: 49
Bio & Compensation - Reuters
Richard P. Powers
Director
Age: 65
Bio & Compensation - Reuters
John Simon Ph.D.
Director
Age: 66
Bio & Compensation - Reuters
William H. Younger Jr.
Director
Age: 59
Bio & Compensation - Reuters
Jeffrey L. Purvin
Director
Age: 57
Bio & Compensation - Reuters